Synthesis and Anti-HBV Activity of Thiouracils Linked via S and N-1 to the 5-Position of Methyl β-D-Ribofuranoside

Nucleosides, Nucleotides and Nucleic Acids

Volumn 22, Issue 11, 2003, Pages 2027-2038

  Abdel Rahman, Adel A H ^a   Abdel Megied, Ahmed E S ^a   Goda, Adel E S ^a   Zeid, Ibrahim F ^a   El Ashry, El Sayed H ^b  

^a Menoufia University   (Egypt)

^b Alexandria University Faculty Of Science   (Egypt)

Author keywords

Nucleoside; Ribofuranoside; Thiouracil

Indexed keywords

METHYL 2,3 O ISOPROPYLIDENE 5 O 4 TOLUENESULFONYL BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 2,3 O ISOPROPYLIDENE 5 (5 METHYLURACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 2,3 O ISOPROPYLIDENE 5 (6 METHYLURACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 2,3 O ISOPROPYLIDENE 5 (6 PROPYLURACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 2,3 O ISOPROPYLIDENE 5 (URACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 (5 METHYLURACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 (6 METHYLURACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 (6 PROPYLURACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 (URACIL 2 YL)THIO BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [2 (METHYLSULFANYL) 6 PROPYLURACIL 1 YL] 2,3 O ISOPROPYLIDENE BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [2 (METHYLSULFANYL) 6 PROPYLURACIL 1 YL] BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [2 (METHYLSULFANYL)URACIL 1 YL] 2,3 O ISOPROPYLIDENE BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [2 (METHYLSULFANYL)URACIL 1 YL] BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [5 METHYL 2 (METHYLSULFANYL)URACIL 1 YL] 2,3 O ISOPROPYLIDENE BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [5 METHYL 2 (METHYLSULFANYL)URACIL 1 YL] BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [6 METHYL 2 (METHYLSULFANYL)URACIL 1 YL] 2,3 O ISOPROPYLIDENE BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 [6 METHYL 2 (METHYLSULFANYL)URACIL 1 YL] BETA DEXTRO RIBOFURANOSIDE; METHYL 5 DEOXY 5 IODO 2,3 O ISOPROPYLIDENE DEXTRO RIBOFURANOSIDE; METHYL GROUP; SODIUM; THIOURACIL DERIVATIVE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ALKYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DEPROTECTION REACTION; DRUG SCREENING; DRUG SYNTHESIS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; REACTION ANALYSIS;

ANIMALS; ANTIVIRAL AGENTS; HEPATITIS B VIRUS; HUMANS; RIBOSE; THIOURACIL;

HEPATITIS B VIRUS;

EID: 0345714904     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120026404     Document Type: Article

References (32)

1. Pai, S.B.; Liu, S.-H.; Zhu, Y.-L.; Chu, C.K.; Cheng, Y.C. Inhibition of hepatitis B Virus by a novel L-nucleoside, 2′-fluoro-5-methyl-β -L-arabinofuranosyl uracil. Antimicrob. Agents Chemother. 1996, 40, 380.
2. Ma, T.; Lin, J.-S.; Newton, M.G.; Cheng, Y.-C.; Chu, C.K. Synthesis ans antihepatitis B virus activity of 9-(2-deoxy-2-fluoro-β -L-arabinofuranosyl)purine nucleosides. J. Med. Chem. 1997, 40, 2750.
3. Beach, J.W.; Jeong, L.S.; Alves, A.J.; Pohl, D.; Kim, H.O.; Chang, C.-N. ; Doong, S.-L.; Schinazi, R.F.; Cheng, Y.-C.; Chu, C.K. Synthesis of enantiomerically pure (2′R, 5′ S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J. Org. Chem. 1992, 57, 2217; Jeong, L.S.; Alves, A.J.; Carrigan, S.W.; Kim, H.O.; Beach, C.-W.; Chu, C.K. An efficient synthesis of enantiomerically pure (+)-(2S, 5R)-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine[(+)-BCH-189] from D-galactose. Tetrahedron Lett. 1992, 33, 595; Coates, J.A.V.; Cammack, N.S.; Jenkinson, H.J.; Mutton, I.M.; Pearson, B.A.; Storer, R.; Cameron, J.M.; Penn, C.R. The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrob. Agents Chemother. 1992, 36, 202; Grove, K.L.; Guo, X.; Liu, S.-H.; Gao, Z.; Chu, C.K.; Cheng, Y.-C. Anticancer activity of β-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res. 1995, 55, 3008.
4. Beach, J.W.; Jeong, L.S.; Alves, A.J.; Pohl, D.; Kim, H.O.; Chang, C.-N. ; Doong, S.-L.; Schinazi, R.F.; Cheng, Y.-C.; Chu, C.K. Synthesis of enantiomerically pure (2′R, 5′ S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J. Org. Chem. 1992, 57, 2217; Jeong, L.S.; Alves, A.J.; Carrigan, S.W.; Kim, H.O.; Beach, C.-W.; Chu, C.K. An efficient synthesis of enantiomerically pure (+)-(2S, 5R)-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine[(+)-BCH-189] from D-galactose. Tetrahedron Lett. 1992, 33, 595; Coates, J.A.V.; Cammack, N.S.; Jenkinson, H.J.; Mutton, I.M.; Pearson, B.A.; Storer, R.; Cameron, J.M.; Penn, C.R. The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrob. Agents Chemother. 1992, 36, 202; Grove, K.L.; Guo, X.; Liu, S.-H.; Gao, Z.; Chu, C.K.; Cheng, Y.-C. Anticancer activity of β-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res. 1995, 55, 3008.
5. Beach, J.W.; Jeong, L.S.; Alves, A.J.; Pohl, D.; Kim, H.O.; Chang, C.-N. ; Doong, S.-L.; Schinazi, R.F.; Cheng, Y.-C.; Chu, C.K. Synthesis of enantiomerically pure (2′R, 5′ S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J. Org. Chem. 1992, 57, 2217; Jeong, L.S.; Alves, A.J.; Carrigan, S.W.; Kim, H.O.; Beach, C.-W.; Chu, C.K. An efficient synthesis of enantiomerically pure (+)-(2S, 5R)-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine[(+)-BCH-189] from D-galactose. Tetrahedron Lett. 1992, 33, 595; Coates, J.A.V.; Cammack, N.S.; Jenkinson, H.J.; Mutton, I.M.; Pearson, B.A.; Storer, R.; Cameron, J.M.; Penn, C.R. The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrob. Agents Chemother. 1992, 36, 202; Grove, K.L.; Guo, X.; Liu, S.-H.; Gao, Z.; Chu, C.K.; Cheng, Y.-C. Anticancer activity of β-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res. 1995, 55, 3008.
6. Beach, J.W.; Jeong, L.S.; Alves, A.J.; Pohl, D.; Kim, H.O.; Chang, C.-N. ; Doong, S.-L.; Schinazi, R.F.; Cheng, Y.-C.; Chu, C.K. Synthesis of enantiomerically pure (2′R, 5′ S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J. Org. Chem. 1992, 57, 2217; Jeong, L.S.; Alves, A.J.; Carrigan, S.W.; Kim, H.O.; Beach, C.-W.; Chu, C.K. An efficient synthesis of enantiomerically pure (+)-(2S, 5R)-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine[(+)-BCH-189] from D-galactose. Tetrahedron Lett. 1992, 33, 595; Coates, J.A.V.; Cammack, N.S.; Jenkinson, H.J.; Mutton, I.M.; Pearson, B.A.; Storer, R.; Cameron, J.M.; Penn, C.R. The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrob. Agents Chemother. 1992, 36, 202; Grove, K.L.; Guo, X.; Liu, S.-H.; Gao, Z.; Chu, C.K.; Cheng, Y.-C. Anticancer activity of β-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res. 1995, 55, 3008.
7. Ajitkumar, P.; Cherayil, J.D. Thionucleosides in transfer ribonucleic acid: Diversity, structure, biosynthesis and function. Chem. Rev. 1988, 52, 103.
8. Kulikowski, T.; Bretmer, M.; Dzik, J.M.; Zielinski, Z.; Ciesla, J.; Roda, W.; Vilpo, J.A.; Shugar, D. Synthesis and antimetabolic properties of 4,5-substituted pyrimidine 2′-deoxynucleosides and their 5′-monophosphates. Nuc. Acid. Res. Symp. Ser. 1987, 18, 61.
9. Matthes, E.; Lehmann, C.; Von Janta-Lipinski, M.; Scholz, D. Inhibition of HIV-replication by 3′-fluoro-modified nucleosides with low cytotoxicity. Biochim. Biophys. Res. Commun. 1989, 165, 488.
10. 2 -alkyl-2-thiouridines. Synthesis 1996, 2, 237.
11. 2 -alkyl-2-thiouridines. Synthesis 1996, 2, 237.
12. 2 -alkyl-2-thiouridines. Synthesis 1996, 2, 237.
13. Abdel-Rahman, A.A.-H. Synthesis of glucosylated 2-methylthiouracils as new antiviral agents. Afinidad 1997, 468, 135; Synthesis of some 2-methylthiouracil nucleosides and its 5-halo analogues of 2-acetamido-2-deoxy-D-glucose. Pharmazie 2001, 56, 773; Abdel-Rahman, A.A.-H.; Abdel-Bary, H.M.; Pedersen, E.B.; Nielsen, C. Synthesis of 4-methylthio analogues of FLT and AZT and their evaluation against HIV. Arch. Pharm. 1995, 328, 67; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of (S)-1-(2′,3′-dihydroxypropyl)-2-alkylthiouracils as new antiviral agents. Pharmazie 1998, 53, 377; Zeid, I.F.; Abdel-Rahman, A.A.-H.; Abdel-Megied, A.E.-S.; El-Etrawy, A.S. Synthesis of new thiolated acyclonucleosides with potential anti-HBV activity. Nucleosides & Nucleotides 1999, 18, 95; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of 2′,3′-dideoxynucleosides from 2-(methylsulfanyl)uracils. J. Chem. Res. (S) 2002, 251, (M) 2002, 601.
14. Abdel-Rahman, A.A.-H. Synthesis of glucosylated 2-methylthiouracils as new antiviral agents. Afinidad 1997, 468, 135; Synthesis of some 2-methylthiouracil nucleosides and its 5-halo analogues of 2-acetamido-2-deoxy-D-glucose. Pharmazie 2001, 56, 773; Abdel-Rahman, A.A.-H.; Abdel-Bary, H.M.; Pedersen, E.B.; Nielsen, C. Synthesis of 4-methylthio analogues of FLT and AZT and their evaluation against HIV. Arch. Pharm. 1995, 328, 67; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of (S)-1-(2′,3′-dihydroxypropyl)-2-alkylthiouracils as new antiviral agents. Pharmazie 1998, 53, 377; Zeid, I.F.; Abdel-Rahman, A.A.-H.; Abdel-Megied, A.E.-S.; El-Etrawy, A.S. Synthesis of new thiolated acyclonucleosides with potential anti-HBV activity. Nucleosides & Nucleotides 1999, 18, 95; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of 2′,3′-dideoxynucleosides from 2-(methylsulfanyl)uracils. J. Chem. Res. (S) 2002, 251, (M) 2002, 601.
15. Abdel-Rahman, A.A.-H. Synthesis of glucosylated 2-methylthiouracils as new antiviral agents. Afinidad 1997, 468, 135; Synthesis of some 2-methylthiouracil nucleosides and its 5-halo analogues of 2-acetamido-2-deoxy-D-glucose. Pharmazie 2001, 56, 773; Abdel-Rahman, A.A.-H.; Abdel-Bary, H.M.; Pedersen, E.B.; Nielsen, C. Synthesis of 4-methylthio analogues of FLT and AZT and their evaluation against HIV. Arch. Pharm. 1995, 328, 67; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of (S)-1-(2′,3′-dihydroxypropyl)-2-alkylthiouracils as new antiviral agents. Pharmazie 1998, 53, 377; Zeid, I.F.; Abdel-Rahman, A.A.-H.; Abdel-Megied, A.E.-S.; El-Etrawy, A.S. Synthesis of new thiolated acyclonucleosides with potential anti-HBV activity. Nucleosides & Nucleotides 1999, 18, 95; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of 2′,3′-dideoxynucleosides from 2-(methylsulfanyl)uracils. J. Chem. Res. (S) 2002, 251, (M) 2002, 601.
16. Abdel-Rahman, A.A.-H. Synthesis of glucosylated 2-methylthiouracils as new antiviral agents. Afinidad 1997, 468, 135; Synthesis of some 2-methylthiouracil nucleosides and its 5-halo analogues of 2-acetamido-2-deoxy-D-glucose. Pharmazie 2001, 56, 773; Abdel-Rahman, A.A.-H.; Abdel-Bary, H.M.; Pedersen, E.B.; Nielsen, C. Synthesis of 4-methylthio analogues of FLT and AZT and their evaluation against HIV. Arch. Pharm. 1995, 328, 67; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of (S)-1-(2′,3′-dihydroxypropyl)-2-alkylthiouracils as new antiviral agents. Pharmazie 1998, 53, 377; Zeid, I.F.; Abdel-Rahman, A.A.-H.; Abdel-Megied, A.E.-S.; El-Etrawy, A.S. Synthesis of new thiolated acyclonucleosides with potential anti-HBV activity. Nucleosides & Nucleotides 1999, 18, 95; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of 2′,3′-dideoxynucleosides from 2-(methylsulfanyl)uracils. J. Chem. Res. (S) 2002, 251, (M) 2002, 601.
17. Abdel-Rahman, A.A.-H. Synthesis of glucosylated 2-methylthiouracils as new antiviral agents. Afinidad 1997, 468, 135; Synthesis of some 2-methylthiouracil nucleosides and its 5-halo analogues of 2-acetamido-2-deoxy-D-glucose. Pharmazie 2001, 56, 773; Abdel-Rahman, A.A.-H.; Abdel-Bary, H.M.; Pedersen, E.B.; Nielsen, C. Synthesis of 4-methylthio analogues of FLT and AZT and their evaluation against HIV. Arch. Pharm. 1995, 328, 67; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of (S)-1-(2′,3′-dihydroxypropyl)-2-alkylthiouracils as new antiviral agents. Pharmazie 1998, 53, 377; Zeid, I.F.; Abdel-Rahman, A.A.-H.; Abdel-Megied, A.E.-S.; El-Etrawy, A.S. Synthesis of new thiolated acyclonucleosides with potential anti-HBV activity. Nucleosides & Nucleotides 1999, 18, 95; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of 2′,3′-dideoxynucleosides from 2-(methylsulfanyl)uracils. J. Chem. Res. (S) 2002, 251, (M) 2002, 601.
18. Abdel-Rahman, A.A.-H. Synthesis of glucosylated 2-methylthiouracils as new antiviral agents. Afinidad 1997, 468, 135; Synthesis of some 2-methylthiouracil nucleosides and its 5-halo analogues of 2-acetamido-2-deoxy-D-glucose. Pharmazie 2001, 56, 773; Abdel-Rahman, A.A.-H.; Abdel-Bary, H.M.; Pedersen, E.B.; Nielsen, C. Synthesis of 4-methylthio analogues of FLT and AZT and their evaluation against HIV. Arch. Pharm. 1995, 328, 67; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of (S)-1-(2′,3′-dihydroxypropyl)-2-alkylthiouracils as new antiviral agents. Pharmazie 1998, 53, 377; Zeid, I.F.; Abdel-Rahman, A.A.-H.; Abdel-Megied, A.E.-S.; El-Etrawy, A.S. Synthesis of new thiolated acyclonucleosides with potential anti-HBV activity. Nucleosides & Nucleotides 1999, 18, 95; Abdel-Rahman, A.A.-H.; Abdel-Aal, M.T. Synthesis of 2′,3′-dideoxynucleosides from 2-(methylsulfanyl)uracils. J. Chem. Res. (S) 2002, 251, (M) 2002, 601.
19. El Ashry, E.S.H.; Abdel-Rahman, A.A.-H.; Rashed, N.; Rasheed, H.A. Synthesis and anti-hepatitis B virus activity of some 2,3-dihydroxyprop-1-yl unnatural hetaryls. Arch. Pharm. 1999, 332, 327; Homoacyclovir analogues of unnatural bases and their activity against hepatitis B virus. Pharmazie 1999, 54, 893.
20. El Ashry, E.S.H.; Abdel-Rahman, A.A.-H.; Rashed, N.; Rasheed, H.A. Synthesis and anti-hepatitis B virus activity of some 2,3-dihydroxyprop-1-yl unnatural hetaryls. Arch. Pharm. 1999, 332, 327; Homoacyclovir analogues of unnatural bases and their activity against hepatitis B virus. Pharmazie 1999, 54, 893.
21. El Ashry, E.S.H.; El Kilany, Y. Acyclonucleosides: Part 1. seco-Nucleosides. Adv. Heterocycl. Chem. 1996, 67, 391; Acyclonucleosides: Part 2. diseco-Nucleosides 1997, 68, 1; Acyclonucleosides: Part 3. tri-, tetra-, and pentaseco-Nucleosides 1998, 69, 129.
22. El Ashry, E.S.H.; El Kilany, Y. Acyclonucleosides: Part 1. seco-Nucleosides. Adv. Heterocycl. Chem. 1996, 67, 391; Acyclonucleosides: Part 2. diseco-Nucleosides 1997, 68, 1; Acyclonucleosides: Part 3. tri-, tetra-, and pentaseco-Nucleosides 1998, 69, 129.
23. El Ashry, E.S.H.; El Kilany, Y. Acyclonucleosides: Part 1. seco-Nucleosides. Adv. Heterocycl. Chem. 1996, 67, 391; Acyclonucleosides: Part 2. diseco-Nucleosides 1997, 68, 1; Acyclonucleosides: Part 3. tri-, tetra-, and pentaseco-Nucleosides 1998, 69, 129.
24. Reist, E.J.; Spencer, R.R.; Wain, M.E.; Junga, I.G.; Goodman, L.; Baker, B.R. Potential anticancer agents. LVII. Synthesis of alkylating agents derived from 6-amino-6-deoxy-D-glucose and 5-amino-5-deoxy-D-ribose. J. Org. Chem. 1961, 26, 2821; Baker, R.; Fletcher, H.G. 2,3,5-Tri-O-benzyl-D-ribosyl and -L-arabinosyl bromides. J. Org. Chem. 1961, 26, 4605; Montogomery, J.A.; Hewson, K. The synthesis of homoribose. J. Org. Chem. 1964, 29, 3436.
25. Reist, E.J.; Spencer, R.R.; Wain, M.E.; Junga, I.G.; Goodman, L.; Baker, B.R. Potential anticancer agents. LVII. Synthesis of alkylating agents derived from 6-amino-6-deoxy-D-glucose and 5-amino-5-deoxy-D-ribose. J. Org. Chem. 1961, 26, 2821; Baker, R.; Fletcher, H.G. 2,3,5-Tri-O-benzyl-D-ribosyl and -L-arabinosyl bromides. J. Org. Chem. 1961, 26, 4605; Montogomery, J.A.; Hewson, K. The synthesis of homoribose. J. Org. Chem. 1964, 29, 3436.
26. Reist, E.J.; Spencer, R.R.; Wain, M.E.; Junga, I.G.; Goodman, L.; Baker, B.R. Potential anticancer agents. LVII. Synthesis of alkylating agents derived from 6-amino-6-deoxy-D-glucose and 5-amino-5-deoxy-D-ribose. J. Org. Chem. 1961, 26, 2821; Baker, R.; Fletcher, H.G. 2,3,5-Tri-O-benzyl-D-ribosyl and -L-arabinosyl bromides. J. Org. Chem. 1961, 26, 4605; Montogomery, J.A.; Hewson, K. The synthesis of homoribose. J. Org. Chem. 1964, 29, 3436.
27. Leonard, N.J.; Carraway, K.L. 5-Amino-5-deoxyribose derivatives. Synthesis and use in preparation of "reversed" nucleosides. J. Heterocyclic Chem. 1966, 3, 485.
28. Kissman, H.M.; Baker, B.R. The synthesis of certain 5-deoxy-D-ribofuranosides. J. Am. Chem. Soc. 1957, 79, 5534.
29. Brown, T.H.; Blakemore, R.C.; Emmett, G.J.; Robin, G.C.; Parsons, M.E.; Anthony, D.A.; Walker, T.F. Isocytosine H2-receptor histamine antagonists. II. Synthesis and evaluation of biological activity at histamine H1- and H2-receptors of 5-(heterocyclyl)methylisocytosines. Eur. J. Med. Chem. 1988, 23, 53.
30. Doong, S.L.; Tasi, C.H.; Schinazi, R.F.; Liotta, D.C.; Cheng, Y.C. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc. Natl. Acad. Sci. USA 1991, 88, 8495.
31. Korba, B.E.; Gerin, J.L. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res. 1992, 19, 55.
32. Fouad, T.; Nielsen, C.; Brunn, L.; Pedersen, E.B. Use of standardization cell culture assay to assess activities of some potent anti-HIV nucleosides analogues against hepatitis B virus replication. Sc. J. Az. Med. Fac. (GIRLS) 1998, 19, 1173.